Skip to main content
Delfa

← All trials/NCT05889637

Completed

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1(GLP-1) Receptor Agonists

Asset

GLP-1 / incretin class catch-all

Listed sites

1

Recruiting sites

-

Actual enrollment

132

Study population

Obesity / overweight

Eligibility highlights

-

Primary endpoints

•Number of subjects that are at risk for aspiration•Number of subjects that are at low risk for aspiration

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT05889637
Org study IDHSC-MS-23-0300

Timeline

Milestones

Study first posted2023-06-05actual
Study start2023-06-06actual
Primary completion2023-07-12actual
Study completion2023-07-12actual
Last update posted2023-08-02actual

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age18 Years
SexAll
Healthy volunteersNot accepted
Sampling methodNon probability sample

Study population text

subjects presenting for elective surgery who are on Glucagon-Like peptide-1 agonist subcutaneous injection, once weekly will be included

Inclusion criteria

•Patients taking GLP-1receptor agonists (N=62)
•Patients not taking GLP-1 receptor agonists (N=62)

Exclusion criteria

•Previous gastric resection or bypass
•Gastric band in situ
•Previous fundoplication
•Large hiatal hernia
•Pregnant patients
•Recent trauma
•Inability to turn to the right lateral decubitus position

Endpoints (12)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)
8
Safety / tolerability / PK
2
Weight & body composition
1
Glycemic / diabetes
1

Weight & body composition

1 endpoint
Secondary/protocol endpoint

Body mass Index (BMI)

Time frame:end of ultrasound

descriptive

Glycemic / diabetes

1 endpoint
Secondary/protocol endpoint

Number of participants with diabetes

Time frame:end of ultrasound

event count, event

Safety / tolerability / PK

2 endpoints
Secondary/protocol endpoint

Number of participants with reported nothing by mouth (NPO) status

Time frame:end of ultrasound

event count, event

Secondary/protocol endpoint

Number of participants with Gastroesophageal reflux disease (GERD)

Time frame:end of ultrasound

event count, event

Other (unclassified)

8 endpoints
Primary/protocol endpoint/low confidence

Number of subjects that are at risk for aspiration

Time frame:end of ultrasound

event count, event

Primary/protocol endpoint/low confidence

Number of subjects that are at low risk for aspiration

Time frame:end of ultrasound

event count, event

Secondary/protocol endpoint/low confidence

Age

Time frame:end of ultrasound

descriptive

Secondary/protocol endpoint/low confidence

Number of participants that are male as indicated in the medical records

Time frame:end of ultrasound

event count, event

Secondary/protocol endpoint/low confidence

Number of participants that are female as indicated in the medical records

Time frame:end of ultrasound

event count, event

Secondary/protocol endpoint/low confidence

Physical status as assessed by the American Society of Anesthesiologists (ASA) physical status classification system

Time frame:end of ultrasound

categorical status, descriptive

Secondary/protocol endpoint/low confidence

Pain severity as assessed by the numeric scale

Time frame:end of ultrasound

descriptive

Secondary/protocol endpoint/low confidence

Number of participants that have use opioids preoperatively

Time frame:end of ultrasound

event count, event

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 6, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.